Rohto Pharmaceutical Co.,Ltd. (RPHCF)
USD 20.09
(-24.56%)
USD 20.09
(-24.56%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 117.23 Billion JPY | 15231.28% |
| 2023 | 764.69 Million JPY | 7.94% |
| 2022 | 708.46 Million JPY | -5.78% |
| 2021 | 751.95 Million JPY | -9.62% |
| 2020 | 831.96 Million JPY | 4.92% |
| 2019 | 792.98 Million JPY | 4.09% |
| 2018 | 761.78 Million JPY | 13.85% |
| 2017 | 669.11 Million JPY | -8.97% |
| 2016 | 735.05 Million JPY | -99.05% |
| 2015 | 77.43 Billion JPY | 11.69% |
| 2014 | 69.33 Billion JPY | 12.75% |
| 2013 | 61.48 Billion JPY | 8.13% |
| 2012 | 56.86 Billion JPY | 28.82% |
| 2011 | 44.14 Billion JPY | -0.04% |
| 2010 | 44.16 Billion JPY | 1.84% |
| 2009 | 43.36 Billion JPY | 4.17% |
| 2008 | 41.62 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 FY | 117.23 Billion JPY | 15230.63% |
| 2024 Q4 | 35.07 Billion JPY | 16929.31% |
| 2024 Q3 | 205.99 Million JPY | 7.39% |
| 2024 Q2 | 191.81 Million JPY | 14.74% |
| 2024 Q1 | 167.17 Million JPY | -27.25% |
| 2023 Q3 | 202.26 Million JPY | 17.04% |
| 2023 Q4 | 229.78 Million JPY | 13.61% |
| 2023 Q1 | 156.16 Million JPY | -29.05% |
| 2023 Q2 | 172.82 Million JPY | 10.67% |
| 2023 FY | 764.69 Million JPY | 7.94% |
| 2022 Q3 | 188.41 Million JPY | -0.46% |
| 2022 Q4 | 220.08 Million JPY | 16.81% |
| 2022 FY | 708.46 Million JPY | -5.78% |
| 2022 Q1 | 162.07 Million JPY | -27.99% |
| 2022 Q2 | 189.28 Million JPY | 16.79% |
| 2021 Q3 | 21.47 Billion JPY | 8.74% |
| 2021 Q2 | 19.74 Billion JPY | 6.81% |
| 2021 FY | 751.95 Million JPY | -9.62% |
| 2021 Q1 | 18.48 Billion JPY | -31.44% |
| 2021 Q4 | 225.07 Million JPY | -98.95% |
| 2020 FY | 831.96 Million JPY | 4.92% |
| 2020 Q3 | 21.54 Billion JPY | -5.23% |
| 2020 Q4 | 26.96 Billion JPY | 25.14% |
| 2020 Q1 | 20.43 Billion JPY | -20.81% |
| 2020 Q2 | 22.73 Billion JPY | 11.23% |
| 2019 Q4 | 25.8 Billion JPY | 18.54% |
| 2019 FY | 792.98 Million JPY | 4.09% |
| 2019 Q3 | 21.77 Billion JPY | -2.71% |
| 2019 Q2 | 22.37 Billion JPY | 18.73% |
| 2019 Q1 | 18.84 Billion JPY | -24.74% |
| 2018 Q2 | 19.8 Billion JPY | 18.04% |
| 2018 Q1 | 16.77 Billion JPY | -27.05% |
| 2018 FY | 761.78 Million JPY | 13.85% |
| 2018 Q4 | 25.04 Billion JPY | 23.16% |
| 2018 Q3 | 20.33 Billion JPY | 2.69% |
| 2017 Q2 | 18.65 Billion JPY | 13.71% |
| 2017 FY | 669.11 Million JPY | -8.97% |
| 2017 Q1 | 16.4 Billion JPY | -31.48% |
| 2017 Q4 | 22.99 Billion JPY | 29.03% |
| 2017 Q3 | 17.82 Billion JPY | -4.46% |
| 2016 FY | 735.05 Million JPY | -99.05% |
| 2016 Q2 | 19.79 Billion JPY | 6.95% |
| 2016 Q4 | 23.94 Billion JPY | 12.5% |
| 2016 Q1 | 18.5 Billion JPY | -19.66% |
| 2016 Q3 | 21.28 Billion JPY | 7.54% |
| 2015 Q4 | 23.03 Billion JPY | 13.76% |
| 2015 Q2 | 17.4 Billion JPY | 3.94% |
| 2015 Q1 | 16.74 Billion JPY | -18.88% |
| 2015 Q3 | 20.25 Billion JPY | 16.36% |
| 2015 FY | 77.43 Billion JPY | 11.69% |
| 2014 Q4 | 20.63 Billion JPY | 16.72% |
| 2014 FY | 69.33 Billion JPY | 12.75% |
| 2014 Q3 | 17.68 Billion JPY | 10.91% |
| 2014 Q2 | 15.94 Billion JPY | 5.84% |
| 2014 Q1 | 15.06 Billion JPY | -14.58% |
| 2013 Q1 | 13.8 Billion JPY | 136.72% |
| 2013 Q2 | 14.81 Billion JPY | 7.31% |
| 2013 Q3 | 15.22 Billion JPY | 2.77% |
| 2013 FY | 61.48 Billion JPY | 8.13% |
| 2013 Q4 | 17.63 Billion JPY | 15.81% |
| 2012 FY | 56.86 Billion JPY | 28.82% |
| 2012 Q1 | 12.19 Billion JPY | 123.33% |
| 2012 Q2 | 13.81 Billion JPY | 13.31% |
| 2012 Q3 | 14.18 Billion JPY | 2.62% |
| 2012 Q4 | 5.83 Billion JPY | -58.87% |
| 2011 Q1 | 11.72 Billion JPY | 111.42% |
| 2011 Q4 | 5.46 Billion JPY | -60.59% |
| 2011 Q3 | 13.85 Billion JPY | 5.49% |
| 2011 Q2 | 13.13 Billion JPY | 12.08% |
| 2011 FY | 44.14 Billion JPY | -0.04% |
| 2010 Q1 | 11.88 Billion JPY | 212.13% |
| 2010 FY | 44.16 Billion JPY | 1.84% |
| 2010 Q4 | 5.54 Billion JPY | -59.54% |
| 2010 Q3 | 13.7 Billion JPY | 5.02% |
| 2010 Q2 | 13.04 Billion JPY | 9.74% |
| 2009 Q2 | 13.71 Billion JPY | 0.0% |
| 2009 FY | 43.36 Billion JPY | 4.17% |
| 2009 Q4 | 3.8 Billion JPY | -72.67% |
| 2009 Q3 | 13.93 Billion JPY | 1.66% |
| 2008 FY | 41.62 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Science to Consumers, Inc. | - USD | -Infinity% |
| Bemax Inc. | 141.91 Thousand USD | -82605470.783% |
| Bruush Oral Care Inc. | 1.81 Million USD | -6476650.205% |
| CCA Industries, Inc. | 10.67 Million USD | -1097688.822% |
| DSwiss, Inc. | 367.64 Thousand USD | -31887281.102% |
| EOS, Inc. | 966.48 Thousand USD | -12129718.745% |
| Greyson International, Inc. | 20.36 Thousand USD | -575659119.249% |
| Happy Town Holdings Inc. | - USD | -Infinity% |
| Horrison Resources Inc. | - USD | -Infinity% |
| Infusion Brands International, Inc. | 14.21 Million USD | -824807.27% |
| Mandom Corporation | 184.34 Million USD | -63495.415% |
| Naples Soap Company Inc. | - USD | -Infinity% |
| Emo Capital Corp. | 543.89 Thousand USD | -21554283.759% |
| Oliveda International, Inc. | 2.88 Million USD | -4068607.088% |
| PacificHealth Laboratories, Inc. | 3.46 Million USD | -3386432.961% |
| Prosperous Future Holdings Limited | 19.39 Million USD | -604320.213% |
| PURE Bioscience, Inc. | 4.28 Million USD | -2737070.208% |
| PayChest, Inc. | - USD | -Infinity% |
| Skinvisible, Inc. | 510.37 Thousand USD | -22969873.059% |
| Sentient Brands Holdings Inc. | 250.95 Thousand USD | -46713905.077% |
| Sunset Capital Assets, Inc. | 202.4 Thousand USD | -57920770.347% |
| The Stephan Co. | 2.69 Million USD | -4353149.165% |
| Turner Valley Oil & Gas, Inc. | 145 Thousand USD | -80848572.096% |
| Winning Brands Corporation | 327.15 Thousand USD | -35833546.637% |
| Warpaint London PLC | 21.97 Million USD | -533347.892% |
| Zoono Group Limited | 251.07 Thousand USD | -46693252.452% |
| Zurvita Holdings, Inc. | 4.17 Million USD | -2809658.815% |